BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33822051)

  • 1. Influence of saccharide modifications on heparin lyase III substrate specificities.
    Wu J; Chopra P; Boons GJ; Zaia J
    Glycobiology; 2022 Mar; 32(3):208-217. PubMed ID: 33822051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 3-
    Chopra P; Joshi A; Wu J; Lu W; Yadavalli T; Wolfert MA; Shukla D; Zaia J; Boons GJ
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33441484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate specificity of the heparin lyases from Flavobacterium heparinum.
    Desai UR; Wang HM; Linhardt RJ
    Arch Biochem Biophys; 1993 Nov; 306(2):461-8. PubMed ID: 8215450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligosaccharide substrate preferences of human extracellular sulfatase Sulf2 using liquid chromatography-mass spectrometry based glycomics approaches.
    Huang Y; Mao Y; Buczek-Thomas JA; Nugent MA; Zaia J
    PLoS One; 2014; 9(8):e105143. PubMed ID: 25127119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity studies on the heparin lyases from Flavobacterium heparinum.
    Desai UR; Wang HM; Linhardt RJ
    Biochemistry; 1993 Aug; 32(32):8140-5. PubMed ID: 8347612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin.
    Nader HB; Kobayashi EY; Chavante SF; Tersariol IL; Castro RA; Shinjo SK; Naggi A; Torri G; Casu B; Dietrich CP
    Glycoconj J; 1999 Jun; 16(6):265-70. PubMed ID: 10579695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct substrate specificities of bacterial heparinases against N-unsubstituted glucosamine residues in heparan sulfate.
    Wei Z; Lyon M; Gallagher JT
    J Biol Chem; 2005 Apr; 280(16):15742-8. PubMed ID: 15705564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin/heparan sulfate N-sulfamidase from Flavobacterium heparinum: structural and biochemical investigation of catalytic nitrogen-sulfur bond cleavage.
    Myette JR; Soundararajan V; Behr J; Shriver Z; Raman R; Sasisekharan R
    J Biol Chem; 2009 Dec; 284(50):35189-200. PubMed ID: 19726673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase.
    Murphy KJ; Merry CL; Lyon M; Thompson JE; Roberts IS; Gallagher JT
    J Biol Chem; 2004 Jun; 279(26):27239-45. PubMed ID: 15047699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved de novo sequencing of heparin/heparan sulfate oligosaccharides by propionylation of sites of sulfation.
    Liang Q; Chopra P; Boons GJ; Sharp JS
    Carbohydr Res; 2018 Jul; 465():16-21. PubMed ID: 29920400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative susceptibilities of the glucosamine-glucuronic acid and N-acetylglucosamine-glucuronic acid linkages to heparin lyase III.
    Chai W; Leteux C; Westling C; Lindahl U; Feizi T
    Biochemistry; 2004 Jul; 43(26):8590-9. PubMed ID: 15222770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of 3-
    Wang Z; Arnold K; Dhurandahare VM; Xu Y; Pagadala V; Labra E; Jeske W; Fareed J; Gearing M; Liu J
    Anal Chem; 2022 Feb; 94(6):2950-2957. PubMed ID: 35107975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a heparan sulfate 3-O-sulfation specific peeling reaction.
    Huang Y; Mao Y; Zong C; Lin C; Boons GJ; Zaia J
    Anal Chem; 2015 Jan; 87(1):592-600. PubMed ID: 25486437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-faceted substrate specificity of heparanase.
    Peterson SB; Liu J
    Matrix Biol; 2013 Jun; 32(5):223-7. PubMed ID: 23499529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative Electron Transfer Dissociation Sequencing of 3-O-Sulfation-Containing Heparan Sulfate Oligosaccharides.
    Wu J; Wei J; Hogan JD; Chopra P; Joshi A; Lu W; Klein J; Boons GJ; Lin C; Zaia J
    J Am Soc Mass Spectrom; 2018 Jun; 29(6):1262-1272. PubMed ID: 29564812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligosaccharide library-based assessment of heparan sulfate 6-O-sulfotransferase substrate specificity.
    Jemth P; Smeds E; Do AT; Habuchi H; Kimata K; Lindahl U; Kusche-Gullberg M
    J Biol Chem; 2003 Jul; 278(27):24371-6. PubMed ID: 12702732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of partial de-O-sulfation of heparin oligosaccharide library.
    Lin J; Zheng L; Liang Q; Jiang L; Wei Z
    Carbohydr Res; 2021 Jan; 499():108226. PubMed ID: 33401230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncovering the detailed mode of cleavage of heparinase I toward structurally defined heparin oligosaccharides.
    Zhang C; Tang F; Zhang J; Cao J; Li H; Liu C
    Int J Biol Macromol; 2019 Dec; 141():756-764. PubMed ID: 31479666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of heparin/heparan sulfate. The D-glucosaminyl 3-O-sulfotransferase reaction: target and inhibitor saccharides.
    Razi N; Lindahl U
    J Biol Chem; 1995 May; 270(19):11267-75. PubMed ID: 7744762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous-Flow Accelerated Sulfation of Heparan Sulfate Intermediates.
    Anand S; Mardhekar S; Raigawali R; Mohanta N; Jain P; D Shanthamurthy C; Gnanaprakasam B; Kikkeri R
    Org Lett; 2020 May; 22(9):3402-3406. PubMed ID: 32310663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.